Global Gene Therapy Supply, Demand and Key Producers, 2026-2032
The global Gene Therapy market size is expected to reach $ 77080 million by 2032, rising at a market growth of 27.0% CAGR during the forecast period (2026-2032).
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
The Gene Therapy market is driven by the growing demand for innovative treatments for rare genetic disorders, cancers, and chronic diseases that lack effective conventional therapies. Advancements in gene editing technologies such as CRISPR/Cas9, improved viral and non-viral delivery vectors, and increasing knowledge of the human genome have made gene therapy a promising option in precision medicine. Regulatory agencies are also offering accelerated approval pathways for breakthrough gene therapies, encouraging investment and speeding up clinical development. In addition, rising public and private funding, along with successful commercialization of landmark therapies like Zolgensma and Luxturna, are fueling confidence and expansion in this market.
Despite its potential, the Gene Therapy market faces several critical challenges, including high development and treatment costs, complex manufacturing processes, and safety concerns. Producing gene therapies requires highly specialized facilities and stringent quality control, leading to limited scalability and high prices, which can exceed millions of dollars per patient. Furthermore, long-term safety data are still lacking, with concerns over immune responses, off-target effects, and durability of treatment outcomes. Regulatory, ethical, and reimbursement hurdles also pose significant barriers to broader adoption. Addressing these challenges is essential to ensure accessibility, affordability, and the long-term success of gene therapy as a mainstream medical solution.
Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%. North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent. In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.
This report studies the global Gene Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gene Therapy total market, 2021-2032, (USD Million)
Global Gene Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Gene Therapy total market, key domestic companies, and share, (USD Million)
Global Gene Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global Gene Therapy total market by Type, CAGR, 2021-2032, (USD Million)
Global Gene Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Gene Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Roche, Akcea Therapeutics, bluebird bio, Sunway Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Gene Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Gene Therapy Market, By Region:
1. How big is the global Gene Therapy market?
2. What is the demand of the global Gene Therapy market?
3. What is the year over year growth of the global Gene Therapy market?
4. What is the total value of the global Gene Therapy market?
5. Who are the Major Players in the global Gene Therapy market?
6. What are the growth factors driving the market demand?
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
The Gene Therapy market is driven by the growing demand for innovative treatments for rare genetic disorders, cancers, and chronic diseases that lack effective conventional therapies. Advancements in gene editing technologies such as CRISPR/Cas9, improved viral and non-viral delivery vectors, and increasing knowledge of the human genome have made gene therapy a promising option in precision medicine. Regulatory agencies are also offering accelerated approval pathways for breakthrough gene therapies, encouraging investment and speeding up clinical development. In addition, rising public and private funding, along with successful commercialization of landmark therapies like Zolgensma and Luxturna, are fueling confidence and expansion in this market.
Despite its potential, the Gene Therapy market faces several critical challenges, including high development and treatment costs, complex manufacturing processes, and safety concerns. Producing gene therapies requires highly specialized facilities and stringent quality control, leading to limited scalability and high prices, which can exceed millions of dollars per patient. Furthermore, long-term safety data are still lacking, with concerns over immune responses, off-target effects, and durability of treatment outcomes. Regulatory, ethical, and reimbursement hurdles also pose significant barriers to broader adoption. Addressing these challenges is essential to ensure accessibility, affordability, and the long-term success of gene therapy as a mainstream medical solution.
Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%. North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent. In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.
This report studies the global Gene Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gene Therapy total market, 2021-2032, (USD Million)
Global Gene Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Gene Therapy total market, key domestic companies, and share, (USD Million)
Global Gene Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global Gene Therapy total market by Type, CAGR, 2021-2032, (USD Million)
Global Gene Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Gene Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Roche, Akcea Therapeutics, bluebird bio, Sunway Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Gene Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Gene Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Viral Gene Therapy
- Non-Viral Gene Therapy
- Neurological Diseases
- Cancer
- Other
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Roche
- Akcea Therapeutics
- bluebird bio
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
- CSL Behring
- BioMarin Pharmaceutical
1. How big is the global Gene Therapy market?
2. What is the demand of the global Gene Therapy market?
3. What is the year over year growth of the global Gene Therapy market?
4. What is the total value of the global Gene Therapy market?
5. Who are the Major Players in the global Gene Therapy market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Gene Therapy Introduction
1.2 World Gene Therapy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Gene Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Gene Therapy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Gene Therapy Revenue (2021-2032)
1.3.3 China Based Company Gene Therapy Revenue (2021-2032)
1.3.4 Europe Based Company Gene Therapy Revenue (2021-2032)
1.3.5 Japan Based Company Gene Therapy Revenue (2021-2032)
1.3.6 South Korea Based Company Gene Therapy Revenue (2021-2032)
1.3.7 ASEAN Based Company Gene Therapy Revenue (2021-2032)
1.3.8 India Based Company Gene Therapy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Gene Therapy Consumption Value (2021-2032)
2.2 World Gene Therapy Consumption Value by Region
2.2.1 World Gene Therapy Consumption Value by Region (2021-2026)
2.2.2 World Gene Therapy Consumption Value Forecast by Region (2027-2032)
2.3 United States Gene Therapy Consumption Value (2021-2032)
2.4 China Gene Therapy Consumption Value (2021-2032)
2.5 Europe Gene Therapy Consumption Value (2021-2032)
2.6 Japan Gene Therapy Consumption Value (2021-2032)
2.7 South Korea Gene Therapy Consumption Value (2021-2032)
2.8 ASEAN Gene Therapy Consumption Value (2021-2032)
2.9 India Gene Therapy Consumption Value (2021-2032)
3 WORLD GENE THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World Gene Therapy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene Therapy in 2025
3.2.3 Global Concentration Ratios (CR8) for Gene Therapy in 2025
3.3 Gene Therapy Company Evaluation Quadrant
3.4 Gene Therapy Market: Overall Company Footprint Analysis
3.4.1 Gene Therapy Market: Region Footprint
3.4.2 Gene Therapy Market: Company Product Type Footprint
3.4.3 Gene Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Gene Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene Therapy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Gene Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Gene Therapy Consumption Value Comparison
4.2.1 United States VS China: Gene Therapy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Gene Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Gene Therapy Companies and Market Share, 2021-2026
4.3.1 United States Based Gene Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene Therapy Revenue, (2021-2026)
4.4 China Based Companies Gene Therapy Revenue and Market Share, 2021-2026
4.4.1 China Based Gene Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene Therapy Revenue, (2021-2026)
4.5 Rest of World Based Gene Therapy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Gene Therapy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Gene Therapy Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Gene Therapy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Viral Gene Therapy
5.2.2 Non-Viral Gene Therapy
5.3 Market Segment by Type
5.3.1 World Gene Therapy Market Size by Type (2021-2026)
5.3.2 World Gene Therapy Market Size by Type (2027-2032)
5.3.3 World Gene Therapy Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Gene Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Neurological Diseases
6.2.2 Cancer
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Gene Therapy Market Size by Application (2021-2026)
6.3.2 World Gene Therapy Market Size by Application (2027-2032)
6.3.3 World Gene Therapy Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Biogen
7.1.1 Biogen Details
7.1.2 Biogen Major Business
7.1.3 Biogen Gene Therapy Product and Services
7.1.4 Biogen Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Biogen Recent Developments/Updates
7.1.6 Biogen Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Gene Therapy Product and Services
7.2.4 Novartis Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Gilead Sciences
7.3.1 Gilead Sciences Details
7.3.2 Gilead Sciences Major Business
7.3.3 Gilead Sciences Gene Therapy Product and Services
7.3.4 Gilead Sciences Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Gilead Sciences Recent Developments/Updates
7.3.6 Gilead Sciences Competitive Strengths & Weaknesses
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Details
7.4.2 Sarepta Therapeutics Major Business
7.4.3 Sarepta Therapeutics Gene Therapy Product and Services
7.4.4 Sarepta Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Sarepta Therapeutics Recent Developments/Updates
7.4.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Details
7.5.2 Alnylam Pharmaceuticals Major Business
7.5.3 Alnylam Pharmaceuticals Gene Therapy Product and Services
7.5.4 Alnylam Pharmaceuticals Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Alnylam Pharmaceuticals Recent Developments/Updates
7.5.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Amgen
7.6.1 Amgen Details
7.6.2 Amgen Major Business
7.6.3 Amgen Gene Therapy Product and Services
7.6.4 Amgen Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Amgen Recent Developments/Updates
7.6.6 Amgen Competitive Strengths & Weaknesses
7.7 Roche
7.7.1 Roche Details
7.7.2 Roche Major Business
7.7.3 Roche Gene Therapy Product and Services
7.7.4 Roche Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Roche Recent Developments/Updates
7.7.6 Roche Competitive Strengths & Weaknesses
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Details
7.8.2 Akcea Therapeutics Major Business
7.8.3 Akcea Therapeutics Gene Therapy Product and Services
7.8.4 Akcea Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Akcea Therapeutics Recent Developments/Updates
7.8.6 Akcea Therapeutics Competitive Strengths & Weaknesses
7.9 bluebird bio
7.9.1 bluebird bio Details
7.9.2 bluebird bio Major Business
7.9.3 bluebird bio Gene Therapy Product and Services
7.9.4 bluebird bio Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 bluebird bio Recent Developments/Updates
7.9.6 bluebird bio Competitive Strengths & Weaknesses
7.10 Sunway Biotech
7.10.1 Sunway Biotech Details
7.10.2 Sunway Biotech Major Business
7.10.3 Sunway Biotech Gene Therapy Product and Services
7.10.4 Sunway Biotech Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Sunway Biotech Recent Developments/Updates
7.10.6 Sunway Biotech Competitive Strengths & Weaknesses
7.11 SIBIONO
7.11.1 SIBIONO Details
7.11.2 SIBIONO Major Business
7.11.3 SIBIONO Gene Therapy Product and Services
7.11.4 SIBIONO Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 SIBIONO Recent Developments/Updates
7.11.6 SIBIONO Competitive Strengths & Weaknesses
7.12 AnGes
7.12.1 AnGes Details
7.12.2 AnGes Major Business
7.12.3 AnGes Gene Therapy Product and Services
7.12.4 AnGes Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 AnGes Recent Developments/Updates
7.12.6 AnGes Competitive Strengths & Weaknesses
7.13 Orchard Therapeutics
7.13.1 Orchard Therapeutics Details
7.13.2 Orchard Therapeutics Major Business
7.13.3 Orchard Therapeutics Gene Therapy Product and Services
7.13.4 Orchard Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 Orchard Therapeutics Recent Developments/Updates
7.13.6 Orchard Therapeutics Competitive Strengths & Weaknesses
7.14 Human Stem Cells Institute
7.14.1 Human Stem Cells Institute Details
7.14.2 Human Stem Cells Institute Major Business
7.14.3 Human Stem Cells Institute Gene Therapy Product and Services
7.14.4 Human Stem Cells Institute Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 Human Stem Cells Institute Recent Developments/Updates
7.14.6 Human Stem Cells Institute Competitive Strengths & Weaknesses
7.15 CSL Behring
7.15.1 CSL Behring Details
7.15.2 CSL Behring Major Business
7.15.3 CSL Behring Gene Therapy Product and Services
7.15.4 CSL Behring Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.15.5 CSL Behring Recent Developments/Updates
7.15.6 CSL Behring Competitive Strengths & Weaknesses
7.16 BioMarin Pharmaceutical
7.16.1 BioMarin Pharmaceutical Details
7.16.2 BioMarin Pharmaceutical Major Business
7.16.3 BioMarin Pharmaceutical Gene Therapy Product and Services
7.16.4 BioMarin Pharmaceutical Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.16.5 BioMarin Pharmaceutical Recent Developments/Updates
7.16.6 BioMarin Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Gene Therapy Industry Chain
8.2 Gene Therapy Upstream Analysis
8.3 Gene Therapy Midstream Analysis
8.4 Gene Therapy Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Gene Therapy Introduction
1.2 World Gene Therapy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Gene Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Gene Therapy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Gene Therapy Revenue (2021-2032)
1.3.3 China Based Company Gene Therapy Revenue (2021-2032)
1.3.4 Europe Based Company Gene Therapy Revenue (2021-2032)
1.3.5 Japan Based Company Gene Therapy Revenue (2021-2032)
1.3.6 South Korea Based Company Gene Therapy Revenue (2021-2032)
1.3.7 ASEAN Based Company Gene Therapy Revenue (2021-2032)
1.3.8 India Based Company Gene Therapy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Gene Therapy Consumption Value (2021-2032)
2.2 World Gene Therapy Consumption Value by Region
2.2.1 World Gene Therapy Consumption Value by Region (2021-2026)
2.2.2 World Gene Therapy Consumption Value Forecast by Region (2027-2032)
2.3 United States Gene Therapy Consumption Value (2021-2032)
2.4 China Gene Therapy Consumption Value (2021-2032)
2.5 Europe Gene Therapy Consumption Value (2021-2032)
2.6 Japan Gene Therapy Consumption Value (2021-2032)
2.7 South Korea Gene Therapy Consumption Value (2021-2032)
2.8 ASEAN Gene Therapy Consumption Value (2021-2032)
2.9 India Gene Therapy Consumption Value (2021-2032)
3 WORLD GENE THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World Gene Therapy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene Therapy in 2025
3.2.3 Global Concentration Ratios (CR8) for Gene Therapy in 2025
3.3 Gene Therapy Company Evaluation Quadrant
3.4 Gene Therapy Market: Overall Company Footprint Analysis
3.4.1 Gene Therapy Market: Region Footprint
3.4.2 Gene Therapy Market: Company Product Type Footprint
3.4.3 Gene Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Gene Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene Therapy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Gene Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Gene Therapy Consumption Value Comparison
4.2.1 United States VS China: Gene Therapy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Gene Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Gene Therapy Companies and Market Share, 2021-2026
4.3.1 United States Based Gene Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene Therapy Revenue, (2021-2026)
4.4 China Based Companies Gene Therapy Revenue and Market Share, 2021-2026
4.4.1 China Based Gene Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene Therapy Revenue, (2021-2026)
4.5 Rest of World Based Gene Therapy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Gene Therapy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Gene Therapy Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Gene Therapy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Viral Gene Therapy
5.2.2 Non-Viral Gene Therapy
5.3 Market Segment by Type
5.3.1 World Gene Therapy Market Size by Type (2021-2026)
5.3.2 World Gene Therapy Market Size by Type (2027-2032)
5.3.3 World Gene Therapy Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Gene Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Neurological Diseases
6.2.2 Cancer
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Gene Therapy Market Size by Application (2021-2026)
6.3.2 World Gene Therapy Market Size by Application (2027-2032)
6.3.3 World Gene Therapy Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Biogen
7.1.1 Biogen Details
7.1.2 Biogen Major Business
7.1.3 Biogen Gene Therapy Product and Services
7.1.4 Biogen Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Biogen Recent Developments/Updates
7.1.6 Biogen Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Gene Therapy Product and Services
7.2.4 Novartis Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Gilead Sciences
7.3.1 Gilead Sciences Details
7.3.2 Gilead Sciences Major Business
7.3.3 Gilead Sciences Gene Therapy Product and Services
7.3.4 Gilead Sciences Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Gilead Sciences Recent Developments/Updates
7.3.6 Gilead Sciences Competitive Strengths & Weaknesses
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Details
7.4.2 Sarepta Therapeutics Major Business
7.4.3 Sarepta Therapeutics Gene Therapy Product and Services
7.4.4 Sarepta Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Sarepta Therapeutics Recent Developments/Updates
7.4.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Details
7.5.2 Alnylam Pharmaceuticals Major Business
7.5.3 Alnylam Pharmaceuticals Gene Therapy Product and Services
7.5.4 Alnylam Pharmaceuticals Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Alnylam Pharmaceuticals Recent Developments/Updates
7.5.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Amgen
7.6.1 Amgen Details
7.6.2 Amgen Major Business
7.6.3 Amgen Gene Therapy Product and Services
7.6.4 Amgen Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Amgen Recent Developments/Updates
7.6.6 Amgen Competitive Strengths & Weaknesses
7.7 Roche
7.7.1 Roche Details
7.7.2 Roche Major Business
7.7.3 Roche Gene Therapy Product and Services
7.7.4 Roche Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Roche Recent Developments/Updates
7.7.6 Roche Competitive Strengths & Weaknesses
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Details
7.8.2 Akcea Therapeutics Major Business
7.8.3 Akcea Therapeutics Gene Therapy Product and Services
7.8.4 Akcea Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Akcea Therapeutics Recent Developments/Updates
7.8.6 Akcea Therapeutics Competitive Strengths & Weaknesses
7.9 bluebird bio
7.9.1 bluebird bio Details
7.9.2 bluebird bio Major Business
7.9.3 bluebird bio Gene Therapy Product and Services
7.9.4 bluebird bio Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 bluebird bio Recent Developments/Updates
7.9.6 bluebird bio Competitive Strengths & Weaknesses
7.10 Sunway Biotech
7.10.1 Sunway Biotech Details
7.10.2 Sunway Biotech Major Business
7.10.3 Sunway Biotech Gene Therapy Product and Services
7.10.4 Sunway Biotech Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Sunway Biotech Recent Developments/Updates
7.10.6 Sunway Biotech Competitive Strengths & Weaknesses
7.11 SIBIONO
7.11.1 SIBIONO Details
7.11.2 SIBIONO Major Business
7.11.3 SIBIONO Gene Therapy Product and Services
7.11.4 SIBIONO Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 SIBIONO Recent Developments/Updates
7.11.6 SIBIONO Competitive Strengths & Weaknesses
7.12 AnGes
7.12.1 AnGes Details
7.12.2 AnGes Major Business
7.12.3 AnGes Gene Therapy Product and Services
7.12.4 AnGes Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 AnGes Recent Developments/Updates
7.12.6 AnGes Competitive Strengths & Weaknesses
7.13 Orchard Therapeutics
7.13.1 Orchard Therapeutics Details
7.13.2 Orchard Therapeutics Major Business
7.13.3 Orchard Therapeutics Gene Therapy Product and Services
7.13.4 Orchard Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 Orchard Therapeutics Recent Developments/Updates
7.13.6 Orchard Therapeutics Competitive Strengths & Weaknesses
7.14 Human Stem Cells Institute
7.14.1 Human Stem Cells Institute Details
7.14.2 Human Stem Cells Institute Major Business
7.14.3 Human Stem Cells Institute Gene Therapy Product and Services
7.14.4 Human Stem Cells Institute Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 Human Stem Cells Institute Recent Developments/Updates
7.14.6 Human Stem Cells Institute Competitive Strengths & Weaknesses
7.15 CSL Behring
7.15.1 CSL Behring Details
7.15.2 CSL Behring Major Business
7.15.3 CSL Behring Gene Therapy Product and Services
7.15.4 CSL Behring Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.15.5 CSL Behring Recent Developments/Updates
7.15.6 CSL Behring Competitive Strengths & Weaknesses
7.16 BioMarin Pharmaceutical
7.16.1 BioMarin Pharmaceutical Details
7.16.2 BioMarin Pharmaceutical Major Business
7.16.3 BioMarin Pharmaceutical Gene Therapy Product and Services
7.16.4 BioMarin Pharmaceutical Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
7.16.5 BioMarin Pharmaceutical Recent Developments/Updates
7.16.6 BioMarin Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Gene Therapy Industry Chain
8.2 Gene Therapy Upstream Analysis
8.3 Gene Therapy Midstream Analysis
8.4 Gene Therapy Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Gene Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Gene Therapy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Gene Therapy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Gene Therapy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Gene Therapy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene Therapy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Gene Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Gene Therapy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Gene Therapy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Gene Therapy Players in 2025
Table 12. World Gene Therapy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Gene Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Gene Therapy Players
Table 15. Gene Therapy Market: Company Product Type Footprint
Table 16. Gene Therapy Market: Company Product Application Footprint
Table 17. Gene Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Gene Therapy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Gene Therapy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Gene Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene Therapy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Gene Therapy Revenue Market Share (2021-2026)
Table 23. China Based Gene Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene Therapy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Gene Therapy Revenue Market Share (2021-2026)
Table 26. Rest of World Based Gene Therapy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Gene Therapy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Gene Therapy Revenue Market Share (2021-2026)
Table 29. World Gene Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Gene Therapy Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Gene Therapy Market Size by Type (2027-2032) & (USD Million)
Table 32. World Gene Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Gene Therapy Market Size by Application (2021-2026) & (USD Million)
Table 34. World Gene Therapy Market Size by Application (2027-2032) & (USD Million)
Table 35. Biogen Basic Information, Manufacturing Base and Competitors
Table 36. Biogen Major Business
Table 37. Biogen Gene Therapy Product and Services
Table 38. Biogen Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Biogen Recent Developments/Updates
Table 40. Biogen Competitive Strengths & Weaknesses
Table 41. Novartis Basic Information, Manufacturing Base and Competitors
Table 42. Novartis Major Business
Table 43. Novartis Gene Therapy Product and Services
Table 44. Novartis Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Novartis Recent Developments/Updates
Table 46. Novartis Competitive Strengths & Weaknesses
Table 47. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 48. Gilead Sciences Major Business
Table 49. Gilead Sciences Gene Therapy Product and Services
Table 50. Gilead Sciences Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Gilead Sciences Recent Developments/Updates
Table 52. Gilead Sciences Competitive Strengths & Weaknesses
Table 53. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
Table 54. Sarepta Therapeutics Major Business
Table 55. Sarepta Therapeutics Gene Therapy Product and Services
Table 56. Sarepta Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Sarepta Therapeutics Recent Developments/Updates
Table 58. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 59. Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Alnylam Pharmaceuticals Major Business
Table 61. Alnylam Pharmaceuticals Gene Therapy Product and Services
Table 62. Alnylam Pharmaceuticals Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Alnylam Pharmaceuticals Recent Developments/Updates
Table 64. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
Table 65. Amgen Basic Information, Manufacturing Base and Competitors
Table 66. Amgen Major Business
Table 67. Amgen Gene Therapy Product and Services
Table 68. Amgen Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Amgen Recent Developments/Updates
Table 70. Amgen Competitive Strengths & Weaknesses
Table 71. Roche Basic Information, Manufacturing Base and Competitors
Table 72. Roche Major Business
Table 73. Roche Gene Therapy Product and Services
Table 74. Roche Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Roche Recent Developments/Updates
Table 76. Roche Competitive Strengths & Weaknesses
Table 77. Akcea Therapeutics Basic Information, Manufacturing Base and Competitors
Table 78. Akcea Therapeutics Major Business
Table 79. Akcea Therapeutics Gene Therapy Product and Services
Table 80. Akcea Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Akcea Therapeutics Recent Developments/Updates
Table 82. Akcea Therapeutics Competitive Strengths & Weaknesses
Table 83. bluebird bio Basic Information, Manufacturing Base and Competitors
Table 84. bluebird bio Major Business
Table 85. bluebird bio Gene Therapy Product and Services
Table 86. bluebird bio Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. bluebird bio Recent Developments/Updates
Table 88. bluebird bio Competitive Strengths & Weaknesses
Table 89. Sunway Biotech Basic Information, Manufacturing Base and Competitors
Table 90. Sunway Biotech Major Business
Table 91. Sunway Biotech Gene Therapy Product and Services
Table 92. Sunway Biotech Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Sunway Biotech Recent Developments/Updates
Table 94. Sunway Biotech Competitive Strengths & Weaknesses
Table 95. SIBIONO Basic Information, Manufacturing Base and Competitors
Table 96. SIBIONO Major Business
Table 97. SIBIONO Gene Therapy Product and Services
Table 98. SIBIONO Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. SIBIONO Recent Developments/Updates
Table 100. SIBIONO Competitive Strengths & Weaknesses
Table 101. AnGes Basic Information, Manufacturing Base and Competitors
Table 102. AnGes Major Business
Table 103. AnGes Gene Therapy Product and Services
Table 104. AnGes Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. AnGes Recent Developments/Updates
Table 106. AnGes Competitive Strengths & Weaknesses
Table 107. Orchard Therapeutics Basic Information, Manufacturing Base and Competitors
Table 108. Orchard Therapeutics Major Business
Table 109. Orchard Therapeutics Gene Therapy Product and Services
Table 110. Orchard Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Orchard Therapeutics Recent Developments/Updates
Table 112. Orchard Therapeutics Competitive Strengths & Weaknesses
Table 113. Human Stem Cells Institute Basic Information, Manufacturing Base and Competitors
Table 114. Human Stem Cells Institute Major Business
Table 115. Human Stem Cells Institute Gene Therapy Product and Services
Table 116. Human Stem Cells Institute Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Human Stem Cells Institute Recent Developments/Updates
Table 118. Human Stem Cells Institute Competitive Strengths & Weaknesses
Table 119. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 120. CSL Behring Major Business
Table 121. CSL Behring Gene Therapy Product and Services
Table 122. CSL Behring Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. CSL Behring Recent Developments/Updates
Table 124. CSL Behring Competitive Strengths & Weaknesses
Table 125. BioMarin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 126. BioMarin Pharmaceutical Major Business
Table 127. BioMarin Pharmaceutical Gene Therapy Product and Services
Table 128. BioMarin Pharmaceutical Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. BioMarin Pharmaceutical Recent Developments/Updates
Table 130. BioMarin Pharmaceutical Competitive Strengths & Weaknesses
Table 131. Global Key Players of Gene Therapy Upstream (Raw Materials)
Table 132. Global Gene Therapy Typical Customers
Table 1. World Gene Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Gene Therapy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Gene Therapy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Gene Therapy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Gene Therapy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene Therapy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Gene Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Gene Therapy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Gene Therapy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Gene Therapy Players in 2025
Table 12. World Gene Therapy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Gene Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Gene Therapy Players
Table 15. Gene Therapy Market: Company Product Type Footprint
Table 16. Gene Therapy Market: Company Product Application Footprint
Table 17. Gene Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Gene Therapy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Gene Therapy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Gene Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene Therapy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Gene Therapy Revenue Market Share (2021-2026)
Table 23. China Based Gene Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene Therapy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Gene Therapy Revenue Market Share (2021-2026)
Table 26. Rest of World Based Gene Therapy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Gene Therapy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Gene Therapy Revenue Market Share (2021-2026)
Table 29. World Gene Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Gene Therapy Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Gene Therapy Market Size by Type (2027-2032) & (USD Million)
Table 32. World Gene Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Gene Therapy Market Size by Application (2021-2026) & (USD Million)
Table 34. World Gene Therapy Market Size by Application (2027-2032) & (USD Million)
Table 35. Biogen Basic Information, Manufacturing Base and Competitors
Table 36. Biogen Major Business
Table 37. Biogen Gene Therapy Product and Services
Table 38. Biogen Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Biogen Recent Developments/Updates
Table 40. Biogen Competitive Strengths & Weaknesses
Table 41. Novartis Basic Information, Manufacturing Base and Competitors
Table 42. Novartis Major Business
Table 43. Novartis Gene Therapy Product and Services
Table 44. Novartis Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Novartis Recent Developments/Updates
Table 46. Novartis Competitive Strengths & Weaknesses
Table 47. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 48. Gilead Sciences Major Business
Table 49. Gilead Sciences Gene Therapy Product and Services
Table 50. Gilead Sciences Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Gilead Sciences Recent Developments/Updates
Table 52. Gilead Sciences Competitive Strengths & Weaknesses
Table 53. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
Table 54. Sarepta Therapeutics Major Business
Table 55. Sarepta Therapeutics Gene Therapy Product and Services
Table 56. Sarepta Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Sarepta Therapeutics Recent Developments/Updates
Table 58. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 59. Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Alnylam Pharmaceuticals Major Business
Table 61. Alnylam Pharmaceuticals Gene Therapy Product and Services
Table 62. Alnylam Pharmaceuticals Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Alnylam Pharmaceuticals Recent Developments/Updates
Table 64. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
Table 65. Amgen Basic Information, Manufacturing Base and Competitors
Table 66. Amgen Major Business
Table 67. Amgen Gene Therapy Product and Services
Table 68. Amgen Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Amgen Recent Developments/Updates
Table 70. Amgen Competitive Strengths & Weaknesses
Table 71. Roche Basic Information, Manufacturing Base and Competitors
Table 72. Roche Major Business
Table 73. Roche Gene Therapy Product and Services
Table 74. Roche Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Roche Recent Developments/Updates
Table 76. Roche Competitive Strengths & Weaknesses
Table 77. Akcea Therapeutics Basic Information, Manufacturing Base and Competitors
Table 78. Akcea Therapeutics Major Business
Table 79. Akcea Therapeutics Gene Therapy Product and Services
Table 80. Akcea Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Akcea Therapeutics Recent Developments/Updates
Table 82. Akcea Therapeutics Competitive Strengths & Weaknesses
Table 83. bluebird bio Basic Information, Manufacturing Base and Competitors
Table 84. bluebird bio Major Business
Table 85. bluebird bio Gene Therapy Product and Services
Table 86. bluebird bio Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. bluebird bio Recent Developments/Updates
Table 88. bluebird bio Competitive Strengths & Weaknesses
Table 89. Sunway Biotech Basic Information, Manufacturing Base and Competitors
Table 90. Sunway Biotech Major Business
Table 91. Sunway Biotech Gene Therapy Product and Services
Table 92. Sunway Biotech Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Sunway Biotech Recent Developments/Updates
Table 94. Sunway Biotech Competitive Strengths & Weaknesses
Table 95. SIBIONO Basic Information, Manufacturing Base and Competitors
Table 96. SIBIONO Major Business
Table 97. SIBIONO Gene Therapy Product and Services
Table 98. SIBIONO Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. SIBIONO Recent Developments/Updates
Table 100. SIBIONO Competitive Strengths & Weaknesses
Table 101. AnGes Basic Information, Manufacturing Base and Competitors
Table 102. AnGes Major Business
Table 103. AnGes Gene Therapy Product and Services
Table 104. AnGes Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. AnGes Recent Developments/Updates
Table 106. AnGes Competitive Strengths & Weaknesses
Table 107. Orchard Therapeutics Basic Information, Manufacturing Base and Competitors
Table 108. Orchard Therapeutics Major Business
Table 109. Orchard Therapeutics Gene Therapy Product and Services
Table 110. Orchard Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Orchard Therapeutics Recent Developments/Updates
Table 112. Orchard Therapeutics Competitive Strengths & Weaknesses
Table 113. Human Stem Cells Institute Basic Information, Manufacturing Base and Competitors
Table 114. Human Stem Cells Institute Major Business
Table 115. Human Stem Cells Institute Gene Therapy Product and Services
Table 116. Human Stem Cells Institute Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Human Stem Cells Institute Recent Developments/Updates
Table 118. Human Stem Cells Institute Competitive Strengths & Weaknesses
Table 119. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 120. CSL Behring Major Business
Table 121. CSL Behring Gene Therapy Product and Services
Table 122. CSL Behring Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. CSL Behring Recent Developments/Updates
Table 124. CSL Behring Competitive Strengths & Weaknesses
Table 125. BioMarin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 126. BioMarin Pharmaceutical Major Business
Table 127. BioMarin Pharmaceutical Gene Therapy Product and Services
Table 128. BioMarin Pharmaceutical Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. BioMarin Pharmaceutical Recent Developments/Updates
Table 130. BioMarin Pharmaceutical Competitive Strengths & Weaknesses
Table 131. Global Key Players of Gene Therapy Upstream (Raw Materials)
Table 132. Global Gene Therapy Typical Customers
LIST OF FIGURES
Figure 1. Gene Therapy Picture
Figure 2. World Gene Therapy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Gene Therapy Total Revenue (2021-2032) & (USD Million)
Figure 4. World Gene Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Gene Therapy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 13. Gene Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 16. World Gene Therapy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 18. China Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. India Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Gene Therapy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Therapy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Therapy Markets in 2025
Figure 27. United States VS China: Gene Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Gene Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Gene Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Gene Therapy Market Size Market Share by Type in 2025
Figure 31. Viral Gene Therapy
Figure 32. Non-Viral Gene Therapy
Figure 33. World Gene Therapy Market Size Market Share by Type (2021-2032)
Figure 34. World Gene Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 35. World Gene Therapy Market Size Market Share by Application in 2025
Figure 36. Neurological Diseases
Figure 37. Cancer
Figure 38. Other
Figure 39. World Gene Therapy Market Size Market Share by Application (2021-2032)
Figure 40. Gene Therapy Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Gene Therapy Picture
Figure 2. World Gene Therapy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Gene Therapy Total Revenue (2021-2032) & (USD Million)
Figure 4. World Gene Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Gene Therapy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 13. Gene Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 16. World Gene Therapy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 18. China Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. India Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Gene Therapy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Therapy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Therapy Markets in 2025
Figure 27. United States VS China: Gene Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Gene Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Gene Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Gene Therapy Market Size Market Share by Type in 2025
Figure 31. Viral Gene Therapy
Figure 32. Non-Viral Gene Therapy
Figure 33. World Gene Therapy Market Size Market Share by Type (2021-2032)
Figure 34. World Gene Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 35. World Gene Therapy Market Size Market Share by Application in 2025
Figure 36. Neurological Diseases
Figure 37. Cancer
Figure 38. Other
Figure 39. World Gene Therapy Market Size Market Share by Application (2021-2032)
Figure 40. Gene Therapy Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
